References of "Delanaye, Pierre"
     in
Bookmark and Share    
See detailNephrology and Clinical Chemistry: the essential link
DELANAYE, Pierre ULg

Book published by Bentham (2012)

Detailed reference viewed: 14 (0 ULg)
Full Text
Peer Reviewed
See detailCystatin C in HIV-infected patients: promising but not yet ready for prime time.
Gagneux-Brunon, Amandine; Mariat, Christophe; DELANAYE, Pierre ULg

in Nephrology Dialysis Transplantation (2012), 27(4), 1305-1313

Detailed reference viewed: 16 (0 ULg)
Full Text
Peer Reviewed
See detailAnorexia Nervosa and the Kidney
BOUQUEGNEAU, Antoine ULg; DUBOIS, Bernard ULg; Krzesinski, Jean-Marie ULg et al

in American Journal of Kidney Diseases (2012), 60(2), 299-307

Anorexia nervosa is a common psychiatric disorder that disproportionately affects adolescents and young adults and is associated with high rates of morbidity and mortality. Anorexia nervosa can affect the ... [more ▼]

Anorexia nervosa is a common psychiatric disorder that disproportionately affects adolescents and young adults and is associated with high rates of morbidity and mortality. Anorexia nervosa can affect the kidney in numerous ways, including increased rates of acute kidney injury and chronic kidney disease, electrolyte abnormalities, and nephrolithiasis. Additionally, the diagnosis and treatment of anorexia nervosa–associated kidney diseases are challenging, reflecting complications such as refeeding syndrome, as well as the limitations of serum creatinine level in this population to estimate kidney function and the psychosocial challenges inherent with treating systemic manifestations of psychiatric conditions. In this review, we discuss kidney diseases and kidney-associated conditions that occur in individuals with anorexia nervosa, summarizing many of the challenges in treating patients with this disease [less ▲]

Detailed reference viewed: 31 (10 ULg)
Full Text
Peer Reviewed
See detailL'estimation du débit de filtration glomérulaire en 2012: quelle valeur ajoutée pour la nouvelle équation CKD-EPI
DELANAYE, Pierre ULg; Mariat, Christophe; Moranne, Olivier et al

in Néphrologie & Thérapeutique (2012), 8

Mesurer ou estimer le debit de filtration glomerulaire (DFG) reste l’un des meilleurs moyens d’apprehender la fonction glomerulaire du rein. En 2009, l’equation Chronic Kidney Disease Epidemiology (CKD ... [more ▼]

Mesurer ou estimer le debit de filtration glomerulaire (DFG) reste l’un des meilleurs moyens d’apprehender la fonction glomerulaire du rein. En 2009, l’equation Chronic Kidney Disease Epidemiology (CKD-EPI) a ete proposee en lieu et place de l’equation Modification of Diet in Renal Disease (MDRD) pour estimer le DFG. Cette nouvelle equation fait partie desormais des toutes dernieres recommandations de la Haute Autorite de sante (HAS). Par rapport a MDRD, la formule CKD-EPI est sensee moins sous-estimer le DFG mesure, principalement dans les valeurs les plus hautes de DFG. Dans cette revue critique de la litterature, nous presenterons et discuterons les performances de cette nouvelle equation. Sur base des articles publies entre 2009 et 2012, nous en soulignerons les avantages, notamment en terme d’estimation de la prevalence de la maladie renale chronique (MRC), mais aussi les faiblesses, principalement dans certaines populations specifiques. En effet, toutes ces equations reposant sur la mesure de la creatinine serique restent des estimations et le nephrologue doit donc garder son sens critique dans l’interpretation de ces resultats. [less ▲]

Detailed reference viewed: 34 (1 ULg)
Full Text
Peer Reviewed
See detailEstimating Glomerular Filtration Rate in 2012 - Does the New Chronic Kidney Disease Epidemiology Equation Fare Better than Older Equations?
DELANAYE, Pierre ULg; Krzesinski, Jean-Marie ULg

in European Nephrology (2012), 6(1), 15-20

Measuring or estimating glomerular filtration rate (GFR) is still considered the best way to apprehend global renal function. In 2009, the Chronic Kidney Disease Epidemiology (CKD-EPI) equation was ... [more ▼]

Measuring or estimating glomerular filtration rate (GFR) is still considered the best way to apprehend global renal function. In 2009, the Chronic Kidney Disease Epidemiology (CKD-EPI) equation was proposed as a better estimator of GFR than the Modification of Diet in Renal Disease (MDRD) study equation. It is supposed to underestimate GFR to a lesser degree in higher GFR levels. In this article, we present and discuss the performances of this new equation. Based on articles published between 2009 and 2012, we underline its advantages, notably better knowledge of chronic kidney disease prevalence, but also its limitations, especially in some specific populations. Our conclusion is that all equations are estimations and that nephrologists should always remain cautions in their interpretation. [less ▲]

Detailed reference viewed: 21 (4 ULg)
Full Text
Peer Reviewed
See detailInterpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values
CAVALIER, Etienne ULg; DELANAYE, Pierre ULg; VRANKEN, Laura ULg et al

in Nephrology Dialysis Transplantation (2012), 27

Background. The recommended target range for serum parathyroid hormone (PTH) in dialysis patients has changed from 150 to 300 pg/mL in the KDOQI guidelines to two to nine times the upper normal limit in ... [more ▼]

Background. The recommended target range for serum parathyroid hormone (PTH) in dialysis patients has changed from 150 to 300 pg/mL in the KDOQI guidelines to two to nine times the upper normal limit in the KDIGO ones. Although inclusion/exclusion criteria for the reference population are highly important, they are usually not mentioned in the commercial kits. In this study, we used the same reference population of vitamin D-replete normal subjects to establish reference values for 10 commercial PTH kits. We evaluated whether this may improve the classification of dialysis patients according to the KDIGO compared to the use of reference values proposed by the manufacturers. Methods. We measured serum PTH with 10 different kits in 149 haemodialysis patients, and 240 25-OH-vitamin D-replete (>75 nmol/L) individuals with an estimated glomerular filtration rate >60 mL/min/1.73 m2. Results. For the 10 kits, our upper normal limit was lower than those of the manufacturers. The difference was, however, variable from one kit to another. The two kits that yielded the lowest and the highest absolute concentrations classified differently 84/149 patients (56.4%) according to the KDOQI and 53/149 (36.2%) according to the KDIGO using the manufacturers’ normal value.Using our normal values significantly decreased the discrepancies with 24/149 patients (16.1%) being still classified differently. Taking the measurement uncertainty into consideration, 8% of the patients only remained differently classified by these two kits. Conclusions. Using the same vitamin-D-replete population to establish the reference range for 10 commercial PTH kits significantly improved the classification of haemodialysis patients according to the KDIGO target range. [less ▲]

Detailed reference viewed: 67 (9 ULg)
Full Text
See detailVascular calcifications in chronic kidney disease: can the Biologist be of some help?
Bargnoux, Anne-Sophie; Morena, Marion; Dupuy, Anne-Marie et al

in DELANAYE, Pierre (Ed.) Clinical Chemistry and Nephrology: the essential link (2012)

Detailed reference viewed: 16 (2 ULg)
Full Text
Peer Reviewed
See detailLe débit de filtration glomérulaire est-il un déterminant de la concentration plasmatique du NGAL aux soins intensifs ?
DELANAYE, Pierre ULg; Claisse, Guillaume; Mehdi, Manoli et al

Poster (2012)

Detailed reference viewed: 22 (4 ULg)
Full Text
See detailHow Measuring Glomerular Filtration Rate? Comparison of reference methods
DELANAYE, Pierre ULg

in Sahay, Manisha (Ed.) Basic Nephrology and Acute Kidney injury (2012)

Detailed reference viewed: 15 (6 ULg)
Full Text
Peer Reviewed
See detailAssessment of kidney function: estimating GFR in children.
DELANAYE, Pierre ULg; Ebert, Natalie

in Nature Reviews Nephrology (2012), 8(9), 503-504

Detailed reference viewed: 6 (1 ULg)
Full Text
Peer Reviewed
See detailMaintenir la PTH entre 2 et 9 fois la valeur de référence supérieure du Laboratoire: d'accord, mais quelle valeur???
CAVALIER, Etienne ULg; DELANAYE, Pierre ULg; Souberbielle, Jean-Claude

in Néphrologie & Thérapeutique (2011, October), 7(5), 411-44727

Detailed reference viewed: 25 (0 ULg)
Full Text
Peer Reviewed
See detailTumor-induced osteomalacia: The tumor may stay hidden!
van der Rest, Catherine; CAVALIER, Etienne ULg; KAUX, Jean-François ULg et al

in Clinical Biochemistry (2011), 44(14-15), 1264-6

We report the case of a patient with severe muscular and articular tenderness that caused almost complete immobility. This subject had severe hypophosphatemia due to hyperphosphaturia. Fibroblast growth ... [more ▼]

We report the case of a patient with severe muscular and articular tenderness that caused almost complete immobility. This subject had severe hypophosphatemia due to hyperphosphaturia. Fibroblast growth factor 23 (FGF-23) was abnormally high and the diagnostic of tumor-induced osteomalacia was made. Despite multiple tests, the tumor was not localized. In this report, we discuss different possible investigations to localize the tumor. Lastly, we review the potential therapy available when tumor is not found and can thus not be excised. [less ▲]

Detailed reference viewed: 48 (17 ULg)
Full Text
Peer Reviewed
See detailEstimating glomerular filtration rate in Asian subjects: where do we stand?
DELANAYE, Pierre ULg; CAVALIER, Etienne ULg; Mariat, Christophe et al

in Kidney International (2011), 80(5), 439-440

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailEstimation du débit de filtration glomérulaire en transplantation rénale: étude multicentrique d'évaluation de la performance de la cystatine C
Masson, I.; Maillard, N.; Jaafar, A. et al

in Néphrologie & Thérapeutique (2011, September), 7(5), 290-91

Detailed reference viewed: 15 (0 ULg)
Full Text
Peer Reviewed
See detailDétection de la maladie rénale chronique dans la population générale: créatinine ou cystatine C?
DELANAYE, Pierre ULg; CAVALIER, Etienne ULg; KRZESINSKI, Jean-Marie ULg

in Néphrologie & Thérapeutique (2011, September), 7(5), 298

Detailed reference viewed: 19 (3 ULg)